Molecule Details
| InChIKey | XEKJJHXPOFNLDM-UHFFFAOYSA-N |
|---|---|
| Compound Name | 4-tert-butyl-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)benzamide |
| Canonical SMILES | CC(C)(C)c1ccc(C(=O)Nc2nnc(S(N)(=O)=O)s2)cc1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 5 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.51 |
| Source | BindingDB;ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile
Target Activities (5)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P00918 | CA2 | Homo sapiens | Human | PF00194 | 7.7 | Ki | ChEMBL;BindingDB |
| P18505 | GABRB1 | Homo sapiens | Human | PF02931 PF02932 | 7.7 | pIC50 | TTD_MultiTarget |
| P00915 | CA1 | Homo sapiens | Human | PF00194 | 6.3 | Ki | ChEMBL;BindingDB |
| O24855 | cynT | Helicobacter pylori (strain ATCC 700392 / 26695) | Pathogen | PF00484 | 7.9 | Ki | ChEMBL |
| Q9ZK30 | Helicobacter pylori (strain J99 / ATCC 700824) | Pathogen | PF00194 | 7.9 | Ki | BindingDB |